Kamil Erozkan, MD

Research Fellow
University Hospitals Cleveland Medical Center, Department of Surgery, Division of Colorectal
Cleveland, OH, United States

2014 - 2019, Ege University - Turkiye, General Surgery, Resident
2021 - 2023, Ankara University - Turkiye, Surgical Oncology, Clinical Fellow
2023 - 2024, Cleveland Clinic, Department of Colorectal Surgery, Research Fellow
Current, University Hospitals of Cleveland, Department of Surgery, Colorectal Surgery Division, Research Fellow

Focusing on colon and rectal surgery.

Disclosure information not submitted.

Presentation(s):

• P106 - Optimal Timing for Rectal Cancer Surgery after Total Neoadjuvant Therapy: When Does It Get Really Challenging?

  Saturday, May 10, 2025
  2:30 PM – 2:38 PM PT

• EP169 - Predicting Tumor Regrowth in Patients Undergoing Watch-and-Wait Surveillance After Total Neoadjuvant Therapy

  Saturday, May 10, 2025
  3:53 PM – 3:58 PM PT

• EP171 - A Paradigm Shift: Declining Surgical Volumes for Rectal Cancer in the Era of Total Neoadjuvant Therapy

  Saturday, May 10, 2025
  3:20 PM – 3:25 PM PT

• EP558 - Concordance Between Clinical and Pathological Staging in Colon Adenocarcinoma: Are We Overconfident in Our Clinical Assessments?

  Sunday, May 11, 2025
  4:11 PM – 4:16 PM PT

• EP581 - Assessing the Relative Impact of Adverse Features on Oncologic Outcomes in Rectal Cancer Surgery

  Sunday, May 11, 2025
  3:55 PM – 4:00 PM PT

• QS133 - Expanding Organ Preservation in Locally Advanced Rectal Cancer After Total Neoadjuvant Therapy with Endoscopic Submucosal Dissection (ESD)

  Sunday, May 11, 2025
  4:05 PM – 4:09 PM PT

• EP674 - Rectal Cancer Patients with T4 Tumors Experience Inferior Response to Total Neoadjuvant Therapy

  Monday, May 12, 2025
  8:27 AM – 8:32 AM PT